Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14515 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Feng-Dan Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluat…. Hauptthemen laut MEDLINE: Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macao Science and Technology Development Fund of Macao SAR, National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Objective
Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra. Despite extensive research, no definitive cure or effective disease‐modifying treatment for PD exists to date. Therefore, the identification of novel therapeutic agents with neuroprotective properties is of utmost importance. Here, we aimed to investigate the potential neuroprotective effects of Carpesii fructus extract (CFE) in both cellular and Caenorhabditis elegans ( C. elegans ) models of PD.
Methods
The neuroprotective effect of CFE in H 2 O 2 ‐ or 6‐OHDA‐induced PC‐12 cells and α‐synuclein‐overexpressing PC‐12 cells were investigated by determining the cell viability, mitochondrial damage, reactive oxygen species (ROS) production, apoptosis, and α‐synuclein expression. In NL5901, BZ555, and N2 worms, the expression of α‐synuclein, motive ability, the viability of dopaminergic neurons, lifespan, and aging‐related phenotypes were investigated. The signaling pathway was detected by Western blotting and validated by employing small inhibitors and RNAi bacteria.
Results
In cellular models of PD, CFE significantly attenuated H 2 O 2 ‐ or 6‐OHDA‐induced toxicity, as evidenced by increased cell viability and reduced apoptosis rate. In addition, CFE treatment suppressed ROS generation and restored mitochondrial membrane potential, highlighting its potential as a mitochondrial protective agent. Furthermore, CFE reduced the expression of α‐synuclein in wide type (WT)‐, A53T‐, A30P‐, or E46K‐α‐synuclein‐overexpressing PC‐12 cells. Our further findings reveal that CFE administration reduced α‐synuclein expression and improved its induced locomotor deficits in NL5901 worms, protected dopaminergic neurons against 6‐OHDA‐induced degeneration in BZ555 worms, extended lifespan, delayed aging‐related phenotypes, and enhanced the ability of stress resistance in N2 worms. Mechanistic studies suggest that the neuroprotective effects of CFE may involve the modulation of the MAPK signaling pathway, including ERK, JNK, and p38, whereas the interference of these pathways attenuated the neuroprotective effect of CFE in vitro and in vivo.
Conclusion
Overall, our study highlights the potential therapeutic value of CFE as a neuroprotective agent in the context of PD. Furthermore, elucidation of the active compounds of CFE will provide valuable insights for the development of novel therapeutic strategies for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysi…
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, China.
ORCID-Profile: An-Guo Wu
Förderung
- Macao Science and Technology Development Fund of Macao SAR
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- Southwest Medical University
Zitieren
APA
Zhu, F. D., Wang, B. D., Qin, D. L., Su, X. H., Yu, L., Wu, J. M., Law, B. Y., Guo, M. S., Yu, C. L., Zhou, X. G., & Wu, A. G. (2024). Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14515
Vancouver
Zhu FD, Wang BD, Qin DL, Su XH, Yu L, Wu JM, et al. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14515
BibTeX
@article{Zhu2024,
author = {Zhu, Feng-Dan and Wang, Bin-Ding and Qin, Da-Lian and Su, Xiao-Hui and Yu, Lu and Wu, Jian-Ming and Law, Betty Yuen-Kwan and Guo, Min-Song and Yu, Chong-Lin and Zhou, Xiao-Gang and Wu, An-Guo},
title = {Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14515}
}
EUVIMED